nodes	percent_of_prediction	percent_of_DWPC	metapath
Gefitinib—CYP2D6—endogenous depression	0.703	1	CbGaD
Gefitinib—ORM1—saliva—endogenous depression	0.00667	0.0329	CbGeAlD
Gefitinib—SBK1—pituitary gland—endogenous depression	0.00399	0.0196	CbGeAlD
Gefitinib—SBK1—midbrain—endogenous depression	0.00351	0.0173	CbGeAlD
Gefitinib—CHEK2—pituitary gland—endogenous depression	0.00347	0.0171	CbGeAlD
Gefitinib—SBK1—thyroid gland—endogenous depression	0.00344	0.0169	CbGeAlD
Gefitinib—CHEK2—adrenal gland—endogenous depression	0.0031	0.0153	CbGeAlD
Gefitinib—HIPK4—endocrine gland—endogenous depression	0.00305	0.015	CbGeAlD
Gefitinib—CHEK2—thyroid gland—endogenous depression	0.00299	0.0147	CbGeAlD
Gefitinib—CSNK1E—forebrain—endogenous depression	0.00294	0.0145	CbGeAlD
Gefitinib—ERBB3—forebrain—endogenous depression	0.00284	0.014	CbGeAlD
Gefitinib—CSNK1E—adrenal cortex—endogenous depression	0.00272	0.0134	CbGeAlD
Gefitinib—SBK1—cerebellum—endogenous depression	0.00272	0.0134	CbGeAlD
Gefitinib—IRAK4—adrenal cortex—endogenous depression	0.00268	0.0132	CbGeAlD
Gefitinib—MKNK2—adrenal cortex—endogenous depression	0.0025	0.0123	CbGeAlD
Gefitinib—MKNK1—adrenal cortex—endogenous depression	0.00247	0.0122	CbGeAlD
Gefitinib—EPHA6—endocrine gland—endogenous depression	0.00241	0.0119	CbGeAlD
Gefitinib—MKNK2—cardiovascular system—endogenous depression	0.00228	0.0112	CbGeAlD
Gefitinib—EPHA6—nervous system—endogenous depression	0.00226	0.0111	CbGeAlD
Gefitinib—MKNK1—cardiovascular system—endogenous depression	0.00225	0.0111	CbGeAlD
Gefitinib—SBK1—brain—endogenous depression	0.00221	0.0109	CbGeAlD
Gefitinib—CSNK1E—pituitary gland—endogenous depression	0.0022	0.0108	CbGeAlD
Gefitinib—HIPK4—brain—endogenous depression	0.00218	0.0108	CbGeAlD
Gefitinib—EPHA6—central nervous system—endogenous depression	0.00217	0.0107	CbGeAlD
Gefitinib—IRAK4—pituitary gland—endogenous depression	0.00217	0.0107	CbGeAlD
Gefitinib—MAP3K19—nervous system—endogenous depression	0.00205	0.0101	CbGeAlD
Gefitinib—EGFR—adrenal gland—endogenous depression	0.00204	0.0101	CbGeAlD
Gefitinib—Minaprine—MAOA—endogenous depression	0.00203	0.131	CrCbGaD
Gefitinib—MAP2K5—brainstem—endogenous depression	0.00203	0.01	CbGeAlD
Gefitinib—MKNK2—pituitary gland—endogenous depression	0.00202	0.00995	CbGeAlD
Gefitinib—MKNK1—pituitary gland—endogenous depression	0.00199	0.00983	CbGeAlD
Gefitinib—MAP3K19—central nervous system—endogenous depression	0.00198	0.00974	CbGeAlD
Gefitinib—EGFR—thyroid gland—endogenous depression	0.00197	0.00972	CbGeAlD
Gefitinib—CSNK1E—adrenal gland—endogenous depression	0.00197	0.00969	CbGeAlD
Gefitinib—CSNK1E—midbrain—endogenous depression	0.00194	0.00957	CbGeAlD
Gefitinib—IRAK4—adrenal gland—endogenous depression	0.00194	0.00954	CbGeAlD
Gefitinib—CHEK2—brain—endogenous depression	0.00192	0.00948	CbGeAlD
Gefitinib—CSNK1E—thyroid gland—endogenous depression	0.0019	0.00935	CbGeAlD
Gefitinib—ERBB3—midbrain—endogenous depression	0.00187	0.00923	CbGeAlD
Gefitinib—IRAK4—thyroid gland—endogenous depression	0.00187	0.0092	CbGeAlD
Gefitinib—STK10—cardiovascular system—endogenous depression	0.00185	0.00914	CbGeAlD
Gefitinib—ERBB3—thyroid gland—endogenous depression	0.00183	0.00902	CbGeAlD
Gefitinib—MAP2K5—adrenal cortex—endogenous depression	0.00181	0.00894	CbGeAlD
Gefitinib—MKNK2—adrenal gland—endogenous depression	0.0018	0.00889	CbGeAlD
Gefitinib—IRAK1—adrenal gland—endogenous depression	0.0018	0.00889	CbGeAlD
Gefitinib—MKNK1—adrenal gland—endogenous depression	0.00178	0.00878	CbGeAlD
Gefitinib—MKNK2—midbrain—endogenous depression	0.00178	0.00878	CbGeAlD
Gefitinib—IRAK1—midbrain—endogenous depression	0.00178	0.00878	CbGeAlD
Gefitinib—MKNK1—midbrain—endogenous depression	0.00176	0.00867	CbGeAlD
Gefitinib—IRAK1—thyroid gland—endogenous depression	0.00174	0.00858	CbGeAlD
Gefitinib—MKNK2—thyroid gland—endogenous depression	0.00174	0.00858	CbGeAlD
Gefitinib—EPHA6—brain—endogenous depression	0.00173	0.0085	CbGeAlD
Gefitinib—MKNK1—thyroid gland—endogenous depression	0.00172	0.00847	CbGeAlD
Gefitinib—CSNK1E—endocrine gland—endogenous depression	0.0017	0.0084	CbGeAlD
Gefitinib—MAP2K5—cardiovascular system—endogenous depression	0.00166	0.00816	CbGeAlD
Gefitinib—ERBB3—endocrine gland—endogenous depression	0.00165	0.00811	CbGeAlD
Gefitinib—CSNK1E—nervous system—endogenous depression	0.0016	0.00786	CbGeAlD
Gefitinib—Minaprine—HTR2C—endogenous depression	0.00158	0.102	CrCbGaD
Gefitinib—IRAK4—nervous system—endogenous depression	0.00157	0.00774	CbGeAlD
Gefitinib—MAP3K19—brain—endogenous depression	0.00157	0.00773	CbGeAlD
Gefitinib—MKNK2—endocrine gland—endogenous depression	0.00156	0.00771	CbGeAlD
Gefitinib—EGFR—cerebellum—endogenous depression	0.00156	0.0077	CbGeAlD
Gefitinib—MKNK1—endocrine gland—endogenous depression	0.00154	0.00761	CbGeAlD
Gefitinib—ERBB3—nervous system—endogenous depression	0.00154	0.00759	CbGeAlD
Gefitinib—CSNK1E—central nervous system—endogenous depression	0.00154	0.00757	CbGeAlD
Gefitinib—IRAK4—central nervous system—endogenous depression	0.00151	0.00745	CbGeAlD
Gefitinib—CSNK1E—cerebellum—endogenous depression	0.0015	0.0074	CbGeAlD
Gefitinib—ERBB3—central nervous system—endogenous depression	0.00148	0.00731	CbGeAlD
Gefitinib—IRAK4—cerebellum—endogenous depression	0.00148	0.00728	CbGeAlD
Gefitinib—STK10—adrenal gland—endogenous depression	0.00147	0.00723	CbGeAlD
Gefitinib—MAP2K5—pituitary gland—endogenous depression	0.00147	0.00723	CbGeAlD
Gefitinib—MKNK2—nervous system—endogenous depression	0.00146	0.00722	CbGeAlD
Gefitinib—Iloperidone—HTR7—endogenous depression	0.00146	0.094	CrCbGaD
Gefitinib—ERBB3—cerebellum—endogenous depression	0.00145	0.00714	CbGeAlD
Gefitinib—MKNK1—nervous system—endogenous depression	0.00145	0.00712	CbGeAlD
Gefitinib—STK10—thyroid gland—endogenous depression	0.00142	0.00698	CbGeAlD
Gefitinib—MKNK2—central nervous system—endogenous depression	0.00141	0.00695	CbGeAlD
Gefitinib—MKNK1—central nervous system—endogenous depression	0.00139	0.00686	CbGeAlD
Gefitinib—MKNK2—cerebellum—endogenous depression	0.00138	0.00679	CbGeAlD
Gefitinib—IRAK1—cerebellum—endogenous depression	0.00138	0.00679	CbGeAlD
Gefitinib—MKNK1—cerebellum—endogenous depression	0.00136	0.0067	CbGeAlD
Gefitinib—Minaprine—SLC6A4—endogenous depression	0.00131	0.0843	CrCbGaD
Gefitinib—MAP2K5—adrenal gland—endogenous depression	0.00131	0.00645	CbGeAlD
Gefitinib—MAP2K5—midbrain—endogenous depression	0.00129	0.00637	CbGeAlD
Gefitinib—STK10—endocrine gland—endogenous depression	0.00127	0.00627	CbGeAlD
Gefitinib—EGFR—brain—endogenous depression	0.00127	0.00625	CbGeAlD
Gefitinib—MAP2K5—thyroid gland—endogenous depression	0.00126	0.00623	CbGeAlD
Gefitinib—Cisapride—HTR2C—endogenous depression	0.00125	0.0804	CrCbGaD
Gefitinib—CSNK1E—brain—endogenous depression	0.00122	0.00601	CbGeAlD
Gefitinib—IRAK4—brain—endogenous depression	0.0012	0.00592	CbGeAlD
Gefitinib—STK10—nervous system—endogenous depression	0.00119	0.00587	CbGeAlD
Gefitinib—ERBB3—brain—endogenous depression	0.00118	0.0058	CbGeAlD
Gefitinib—Iloperidone—HTR2C—endogenous depression	0.00116	0.0742	CrCbGaD
Gefitinib—STK10—central nervous system—endogenous depression	0.00115	0.00565	CbGeAlD
Gefitinib—MAP2K5—endocrine gland—endogenous depression	0.00114	0.0056	CbGeAlD
Gefitinib—Iloperidone—HTR1A—endogenous depression	0.00112	0.0721	CrCbGaD
Gefitinib—STK10—cerebellum—endogenous depression	0.00112	0.00552	CbGeAlD
Gefitinib—MKNK2—brain—endogenous depression	0.00112	0.00552	CbGeAlD
Gefitinib—IRAK1—brain—endogenous depression	0.00112	0.00552	CbGeAlD
Gefitinib—MKNK1—brain—endogenous depression	0.00111	0.00545	CbGeAlD
Gefitinib—MAP2K5—nervous system—endogenous depression	0.00106	0.00524	CbGeAlD
Gefitinib—MAP2K5—central nervous system—endogenous depression	0.00102	0.00504	CbGeAlD
Gefitinib—Minaprine—HTR2A—endogenous depression	0.00101	0.0648	CrCbGaD
Gefitinib—MAP2K5—cerebellum—endogenous depression	0.001	0.00493	CbGeAlD
Gefitinib—ALB—adrenal gland—endogenous depression	0.000933	0.0046	CbGeAlD
Gefitinib—ORM1—endocrine gland—endogenous depression	0.000922	0.00454	CbGeAlD
Gefitinib—Minaprine—CYP2D6—endogenous depression	0.000922	0.0593	CrCbGaD
Gefitinib—STK10—brain—endogenous depression	0.00091	0.00448	CbGeAlD
Gefitinib—ABCG2—adrenal cortex—endogenous depression	0.000883	0.00435	CbGeAlD
Gefitinib—ORM1—nervous system—endogenous depression	0.000863	0.00425	CbGeAlD
Gefitinib—ORM1—central nervous system—endogenous depression	0.000831	0.0041	CbGeAlD
Gefitinib—MAP2K5—brain—endogenous depression	0.000813	0.004	CbGeAlD
Gefitinib—Cisapride—HTR2A—endogenous depression	0.000797	0.0512	CrCbGaD
Gefitinib—Erlotinib—CYP2D6—endogenous depression	0.000774	0.0497	CrCbGaD
Gefitinib—CYP2C9—cardiovascular system—endogenous depression	0.000736	0.00363	CbGeAlD
Gefitinib—Iloperidone—HTR2A—endogenous depression	0.000736	0.0473	CrCbGaD
Gefitinib—Cisapride—CYP2D6—endogenous depression	0.000729	0.0468	CrCbGaD
Gefitinib—ABCG2—pituitary gland—endogenous depression	0.000713	0.00352	CbGeAlD
Gefitinib—CYP2D6—brainstem—endogenous depression	0.000677	0.00333	CbGeAlD
Gefitinib—Iloperidone—CYP2D6—endogenous depression	0.000673	0.0432	CrCbGaD
Gefitinib—CYP2D6—forebrain—endogenous depression	0.000653	0.00322	CbGeAlD
Gefitinib—CYP2C19—endocrine gland—endogenous depression	0.000651	0.00321	CbGeAlD
Gefitinib—ABCG2—adrenal gland—endogenous depression	0.000637	0.00314	CbGeAlD
Gefitinib—ABCG2—midbrain—endogenous depression	0.000629	0.0031	CbGeAlD
Gefitinib—ABCG2—thyroid gland—endogenous depression	0.000615	0.00303	CbGeAlD
Gefitinib—CYP1A1—thyroid gland—endogenous depression	0.000584	0.00288	CbGeAlD
Gefitinib—ALB—brain—endogenous depression	0.000579	0.00285	CbGeAlD
Gefitinib—CYP1A1—endocrine gland—endogenous depression	0.000525	0.00259	CbGeAlD
Gefitinib—CYP3A5—endocrine gland—endogenous depression	0.000513	0.00253	CbGeAlD
Gefitinib—CYP2C9—endocrine gland—endogenous depression	0.000505	0.00249	CbGeAlD
Gefitinib—CYP1A1—nervous system—endogenous depression	0.000491	0.00242	CbGeAlD
Gefitinib—ABCG2—cerebellum—endogenous depression	0.000487	0.0024	CbGeAlD
Gefitinib—CYP1A1—central nervous system—endogenous depression	0.000473	0.00233	CbGeAlD
Gefitinib—ABCB1—forebrain—endogenous depression	0.00047	0.00232	CbGeAlD
Gefitinib—ABCB1—adrenal cortex—endogenous depression	0.000435	0.00215	CbGeAlD
Gefitinib—ABCB1—cardiovascular system—endogenous depression	0.000397	0.00196	CbGeAlD
Gefitinib—ABCG2—brain—endogenous depression	0.000395	0.00195	CbGeAlD
Gefitinib—CYP3A4—endocrine gland—endogenous depression	0.000385	0.0019	CbGeAlD
Gefitinib—CYP2D6—endocrine gland—endogenous depression	0.000379	0.00187	CbGeAlD
Gefitinib—CYP1A1—brain—endogenous depression	0.000375	0.00185	CbGeAlD
Gefitinib—CYP3A4—nervous system—endogenous depression	0.00036	0.00178	CbGeAlD
Gefitinib—CYP2D6—nervous system—endogenous depression	0.000355	0.00175	CbGeAlD
Gefitinib—ABCB1—pituitary gland—endogenous depression	0.000352	0.00173	CbGeAlD
Gefitinib—ABCB1—HIF-1-alpha transcription factor network—ADM—endogenous depression	0.000351	0.00448	CbGpPWpGaD
Gefitinib—MAP2K5—MAPK Signaling Pathway—BDNF—endogenous depression	0.000347	0.00443	CbGpPWpGaD
Gefitinib—CYP3A4—central nervous system—endogenous depression	0.000347	0.00171	CbGeAlD
Gefitinib—EPHA6—Developmental Biology—CACNA1C—endogenous depression	0.000346	0.00442	CbGpPWpGaD
Gefitinib—CYP2D6—central nervous system—endogenous depression	0.000341	0.00168	CbGeAlD
Gefitinib—CYP2D6—cerebellum—endogenous depression	0.000334	0.00164	CbGeAlD
Gefitinib—CYP3A5—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000317	0.00404	CbGpPWpGaD
Gefitinib—ABCB1—adrenal gland—endogenous depression	0.000314	0.00155	CbGeAlD
Gefitinib—ABCB1—midbrain—endogenous depression	0.00031	0.00153	CbGeAlD
Gefitinib—ABCB1—thyroid gland—endogenous depression	0.000303	0.00149	CbGeAlD
Gefitinib—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.000303	0.00386	CbGpPWpGaD
Gefitinib—IRAK4—Innate Immune System—WASF2—endogenous depression	0.000303	0.00386	CbGpPWpGaD
Gefitinib—CYP1A1—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.0003	0.00382	CbGpPWpGaD
Gefitinib—CYP2C19—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.000299	0.00381	CbGpPWpGaD
Gefitinib—IRAK4—Innate Immune System—WASF1—endogenous depression	0.00029	0.0037	CbGpPWpGaD
Gefitinib—ALB—FOXA2 and FOXA3 transcription factor networks—NR3C1—endogenous depression	0.000277	0.00353	CbGpPWpGaD
Gefitinib—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.000276	0.00352	CbGpPWpGaD
Gefitinib—ABCB1—endocrine gland—endogenous depression	0.000273	0.00134	CbGeAlD
Gefitinib—CYP2C9—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.000272	0.00347	CbGpPWpGaD
Gefitinib—CYP2D6—brain—endogenous depression	0.000271	0.00134	CbGeAlD
Gefitinib—EGFR—Axon guidance—ANK3—endogenous depression	0.00027	0.00344	CbGpPWpGaD
Gefitinib—ABCB1—nervous system—endogenous depression	0.000255	0.00126	CbGeAlD
Gefitinib—EGFR—Spinal Cord Injury—BDNF—endogenous depression	0.000247	0.00315	CbGpPWpGaD
Gefitinib—ABCB1—central nervous system—endogenous depression	0.000246	0.00121	CbGeAlD
Gefitinib—CYP2C19—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000245	0.00313	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—WASF2—endogenous depression	0.000241	0.00307	CbGpPWpGaD
Gefitinib—ABCB1—cerebellum—endogenous depression	0.00024	0.00118	CbGeAlD
Gefitinib—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000239	0.00304	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—WASF1—endogenous depression	0.000231	0.00295	CbGpPWpGaD
Gefitinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—endogenous depression	0.000227	0.00289	CbGpPWpGaD
Gefitinib—CYP1A1—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000226	0.00288	CbGpPWpGaD
Gefitinib—CYP2C9—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000224	0.00285	CbGpPWpGaD
Gefitinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—endogenous depression	0.000211	0.00269	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—WASF2—endogenous depression	0.000201	0.00256	CbGpPWpGaD
Gefitinib—ABCB1—brain—endogenous depression	0.000195	0.000961	CbGeAlD
Gefitinib—IRAK1—Innate Immune System—WASF1—endogenous depression	0.000193	0.00245	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—ANK3—endogenous depression	0.000192	0.00245	CbGpPWpGaD
Gefitinib—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000192	0.00244	CbGpPWpGaD
Gefitinib—EGFR—Axon guidance—CACNB2—endogenous depression	0.00019	0.00242	CbGpPWpGaD
Gefitinib—EGFR—MAPK Signaling Pathway—BDNF—endogenous depression	0.000186	0.00238	CbGpPWpGaD
Gefitinib—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000185	0.00235	CbGpPWpGaD
Gefitinib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.000182	0.00232	CbGpPWpGaD
Gefitinib—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000181	0.00231	CbGpPWpGaD
Gefitinib—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.00018	0.00229	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—WASF2—endogenous depression	0.000176	0.00225	CbGpPWpGaD
Gefitinib—EGFR—Axon guidance—CACNA1C—endogenous depression	0.000174	0.00221	CbGpPWpGaD
Gefitinib—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.00017	0.00216	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—WASF1—endogenous depression	0.000169	0.00215	CbGpPWpGaD
Gefitinib—CYP3A5—Biological oxidations—CYP2D6—endogenous depression	0.000169	0.00215	CbGpPWpGaD
Gefitinib—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000168	0.00215	CbGpPWpGaD
Gefitinib—EGFR—Integrated Pancreatic Cancer Pathway—BDNF—endogenous depression	0.000168	0.00214	CbGpPWpGaD
Gefitinib—CYP3A5—Metapathway biotransformation—CYP2D6—endogenous depression	0.000166	0.00212	CbGpPWpGaD
Gefitinib—ABCB1—Allograft Rejection—IL10—endogenous depression	0.000164	0.00209	CbGpPWpGaD
Gefitinib—CYP1A1—Biological oxidations—CYP2D6—endogenous depression	0.000159	0.00203	CbGpPWpGaD
Gefitinib—CYP1A1—Metapathway biotransformation—CYP2D6—endogenous depression	0.000157	0.002	CbGpPWpGaD
Gefitinib—CYP3A5—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000155	0.00198	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—WASF2—endogenous depression	0.000153	0.00195	CbGpPWpGaD
Gefitinib—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000148	0.00189	CbGpPWpGaD
Gefitinib—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000148	0.00188	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—WASF1—endogenous depression	0.000147	0.00187	CbGpPWpGaD
Gefitinib—CYP1A1—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000147	0.00187	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—WASF2—endogenous depression	0.00014	0.00179	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—ADM—endogenous depression	0.00014	0.00179	CbGpPWpGaD
Gefitinib—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000136	0.00174	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—CACNB2—endogenous depression	0.000136	0.00173	CbGpPWpGaD
Gefitinib—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000135	0.00172	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—WASF1—endogenous depression	0.000135	0.00172	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—WASF2—endogenous depression	0.000134	0.00171	CbGpPWpGaD
Gefitinib—CYP2C19—Biological oxidations—CYP2D6—endogenous depression	0.00013	0.00166	CbGpPWpGaD
Gefitinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—endogenous depression	0.000129	0.00165	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—WASF1—endogenous depression	0.000129	0.00164	CbGpPWpGaD
Gefitinib—CYP2C19—Metapathway biotransformation—CYP2D6—endogenous depression	0.000129	0.00164	CbGpPWpGaD
Gefitinib—CYP3A5—Biological oxidations—COMT—endogenous depression	0.000128	0.00163	CbGpPWpGaD
Gefitinib—CYP3A5—Biological oxidations—MAOA—endogenous depression	0.000127	0.00162	CbGpPWpGaD
Gefitinib—CYP3A5—Metapathway biotransformation—COMT—endogenous depression	0.000126	0.00161	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—CACNA1C—endogenous depression	0.000124	0.00158	CbGpPWpGaD
Gefitinib—CYP1A1—Biological oxidations—COMT—endogenous depression	0.000121	0.00154	CbGpPWpGaD
Gefitinib—CYP2C19—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.00012	0.00153	CbGpPWpGaD
Gefitinib—CYP1A1—Biological oxidations—MAOA—endogenous depression	0.00012	0.00153	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—WASF2—endogenous depression	0.000119	0.00152	CbGpPWpGaD
Gefitinib—CYP1A1—Metapathway biotransformation—COMT—endogenous depression	0.000119	0.00152	CbGpPWpGaD
Gefitinib—CYP2C9—Biological oxidations—CYP2D6—endogenous depression	0.000119	0.00151	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—CRH—endogenous depression	0.000117	0.0015	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—OXT—endogenous depression	0.000117	0.0015	CbGpPWpGaD
Gefitinib—CYP2C9—Metapathway biotransformation—CYP2D6—endogenous depression	0.000117	0.00149	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—WASF2—endogenous depression	0.000117	0.00149	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—WASF1—endogenous depression	0.000114	0.00146	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—HTR1A—endogenous depression	0.000113	0.00144	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—WASF1—endogenous depression	0.000112	0.00143	CbGpPWpGaD
Gefitinib—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000111	0.00141	CbGpPWpGaD
Gefitinib—CYP2D6—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000111	0.00141	CbGpPWpGaD
Gefitinib—CYP2C9—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.00011	0.0014	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—HTR2C—endogenous depression	0.000109	0.00139	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—ADM—endogenous depression	0.000109	0.00139	CbGpPWpGaD
Gefitinib—CYP2C19—Biological oxidations—COMT—endogenous depression	9.88e-05	0.00126	CbGpPWpGaD
Gefitinib—CYP2C19—Biological oxidations—MAOA—endogenous depression	9.81e-05	0.00125	CbGpPWpGaD
Gefitinib—CYP2C19—Metapathway biotransformation—COMT—endogenous depression	9.74e-05	0.00124	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—HTR7—endogenous depression	9.57e-05	0.00122	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—WASF2—endogenous depression	9.42e-05	0.0012	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—CRH—endogenous depression	9.14e-05	0.00116	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—OXT—endogenous depression	9.14e-05	0.00116	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—WASF2—endogenous depression	9.08e-05	0.00116	CbGpPWpGaD
Gefitinib—CYP2D6—Biological oxidations—COMT—endogenous depression	9.08e-05	0.00116	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—WASF1—endogenous depression	9.03e-05	0.00115	CbGpPWpGaD
Gefitinib—CYP2D6—Biological oxidations—MAOA—endogenous depression	9.02e-05	0.00115	CbGpPWpGaD
Gefitinib—CYP2C9—Biological oxidations—COMT—endogenous depression	9e-05	0.00115	CbGpPWpGaD
Gefitinib—CYP2D6—Metapathway biotransformation—COMT—endogenous depression	8.96e-05	0.00114	CbGpPWpGaD
Gefitinib—CYP2C9—Biological oxidations—MAOA—endogenous depression	8.94e-05	0.00114	CbGpPWpGaD
Gefitinib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	8.91e-05	0.00114	CbGpPWpGaD
Gefitinib—CYP2C9—Metapathway biotransformation—COMT—endogenous depression	8.88e-05	0.00113	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—HTR1A—endogenous depression	8.8e-05	0.00112	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—WASF1—endogenous depression	8.71e-05	0.00111	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—ADM—endogenous depression	8.62e-05	0.0011	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—HTR2C—endogenous depression	8.49e-05	0.00108	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—endogenous depression	8.49e-05	0.00108	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—ADM—endogenous depression	8.31e-05	0.00106	CbGpPWpGaD
Gefitinib—CYP3A5—Biological oxidations—POMC—endogenous depression	8.26e-05	0.00105	CbGpPWpGaD
Gefitinib—CYP3A4—Biological oxidations—CYP2D6—endogenous depression	7.84e-05	0.000999	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—ADM—endogenous depression	7.83e-05	0.000998	CbGpPWpGaD
Gefitinib—EGFR—Immune System—WASF2—endogenous depression	7.82e-05	0.000997	CbGpPWpGaD
Gefitinib—CYP1A1—Biological oxidations—POMC—endogenous depression	7.8e-05	0.000994	CbGpPWpGaD
Gefitinib—CYP3A4—Metapathway biotransformation—CYP2D6—endogenous depression	7.73e-05	0.000985	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—WASF2—endogenous depression	7.56e-05	0.000964	CbGpPWpGaD
Gefitinib—EGFR—Immune System—WASF1—endogenous depression	7.5e-05	0.000956	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—HTR7—endogenous depression	7.44e-05	0.000948	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—WASF1—endogenous depression	7.25e-05	0.000924	CbGpPWpGaD
Gefitinib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—endogenous depression	7.23e-05	0.000921	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—OXT—endogenous depression	7.22e-05	0.000921	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—CRH—endogenous depression	7.22e-05	0.000921	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—CRH—endogenous depression	6.96e-05	0.000887	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—OXT—endogenous depression	6.96e-05	0.000887	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—HTR1A—endogenous depression	6.95e-05	0.000886	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—ADM—endogenous depression	6.92e-05	0.000882	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—HTR2C—endogenous depression	6.71e-05	0.000856	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—HTR1A—endogenous depression	6.7e-05	0.000854	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—HTR2A—endogenous depression	6.7e-05	0.000854	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—TPH1—endogenous depression	6.64e-05	0.000846	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—OXT—endogenous depression	6.56e-05	0.000836	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—CRH—endogenous depression	6.56e-05	0.000836	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—HTR2C—endogenous depression	6.47e-05	0.000825	CbGpPWpGaD
Gefitinib—CYP2C19—Biological oxidations—POMC—endogenous depression	6.38e-05	0.000814	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—HTR1A—endogenous depression	6.32e-05	0.000805	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—GATA3—endogenous depression	6.12e-05	0.00078	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—HTR2C—endogenous depression	6.1e-05	0.000777	CbGpPWpGaD
Gefitinib—CYP3A4—Biological oxidations—COMT—endogenous depression	5.94e-05	0.000757	CbGpPWpGaD
Gefitinib—CYP3A4—Biological oxidations—MAOA—endogenous depression	5.9e-05	0.000752	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—HTR7—endogenous depression	5.88e-05	0.00075	CbGpPWpGaD
Gefitinib—CYP2D6—Biological oxidations—POMC—endogenous depression	5.87e-05	0.000748	CbGpPWpGaD
Gefitinib—CYP3A4—Metapathway biotransformation—COMT—endogenous depression	5.86e-05	0.000746	CbGpPWpGaD
Gefitinib—CYP2C9—Biological oxidations—POMC—endogenous depression	5.82e-05	0.000742	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—OXT—endogenous depression	5.8e-05	0.000739	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CRH—endogenous depression	5.8e-05	0.000739	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—HTR7—endogenous depression	5.67e-05	0.000722	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—HTR1A—endogenous depression	5.58e-05	0.000711	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—HTR2C—endogenous depression	5.39e-05	0.000687	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—POMC—endogenous depression	5.35e-05	0.000682	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—HTR7—endogenous depression	5.34e-05	0.000681	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—HTR2A—endogenous depression	5.21e-05	0.000664	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—WASF2—endogenous depression	5.06e-05	0.000644	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—TPH2—endogenous depression	5.03e-05	0.000641	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—CACNB2—endogenous depression	5.03e-05	0.000641	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—DPYD—endogenous depression	4.95e-05	0.000631	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—WASF1—endogenous depression	4.85e-05	0.000618	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—TPH1—endogenous depression	4.76e-05	0.000606	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—HTR7—endogenous depression	4.72e-05	0.000602	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—ADM—endogenous depression	4.63e-05	0.000589	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—CACNA1C—endogenous depression	4.6e-05	0.000587	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—TPH1—endogenous depression	4.49e-05	0.000573	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—POMC—endogenous depression	4.16e-05	0.00053	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—HTR2A—endogenous depression	4.12e-05	0.000525	CbGpPWpGaD
Gefitinib—ALB—Metabolism—TPH1—endogenous depression	4.1e-05	0.000522	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—CYP2D6—endogenous depression	4.02e-05	0.000513	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—HTR2A—endogenous depression	3.97e-05	0.000506	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CRH—endogenous depression	3.88e-05	0.000494	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—OXT—endogenous depression	3.88e-05	0.000494	CbGpPWpGaD
Gefitinib—CYP3A4—Biological oxidations—POMC—endogenous depression	3.84e-05	0.000489	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—HTR2A—endogenous depression	3.74e-05	0.000477	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—HTR1A—endogenous depression	3.73e-05	0.000475	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—TPH1—endogenous depression	3.68e-05	0.000469	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—TPH2—endogenous depression	3.61e-05	0.00046	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—CACNB2—endogenous depression	3.61e-05	0.00046	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—HTR2C—endogenous depression	3.6e-05	0.000459	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—TPH1—endogenous depression	3.59e-05	0.000458	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—DPYD—endogenous depression	3.55e-05	0.000452	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—TPH2—endogenous depression	3.41e-05	0.000434	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—CACNB2—endogenous depression	3.41e-05	0.000434	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—TPH1—endogenous depression	3.38e-05	0.000431	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—TPH1—endogenous depression	3.35e-05	0.000427	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—DPYD—endogenous depression	3.35e-05	0.000427	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—HTR2A—endogenous depression	3.31e-05	0.000421	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—CACNA1C—endogenous depression	3.3e-05	0.00042	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—POMC—endogenous depression	3.29e-05	0.000419	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—POMC—endogenous depression	3.17e-05	0.000404	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—HTR7—endogenous depression	3.16e-05	0.000402	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—CACNA1C—endogenous depression	3.12e-05	0.000397	CbGpPWpGaD
Gefitinib—ALB—Metabolism—TPH2—endogenous depression	3.11e-05	0.000396	CbGpPWpGaD
Gefitinib—ALB—Metabolism—CACNB2—endogenous depression	3.11e-05	0.000396	CbGpPWpGaD
Gefitinib—ALB—Metabolism—DPYD—endogenous depression	3.05e-05	0.000389	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—COMT—endogenous depression	3.05e-05	0.000389	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—MAOA—endogenous depression	3.03e-05	0.000386	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—POMC—endogenous depression	3e-05	0.000382	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—POMC—endogenous depression	2.99e-05	0.000381	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—CYP2D6—endogenous depression	2.88e-05	0.000367	CbGpPWpGaD
Gefitinib—ALB—Metabolism—CACNA1C—endogenous depression	2.84e-05	0.000362	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—TPH2—endogenous depression	2.79e-05	0.000355	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—CACNB2—endogenous depression	2.79e-05	0.000355	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—DPYD—endogenous depression	2.74e-05	0.00035	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—POMC—endogenous depression	2.73e-05	0.000348	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—CYP2D6—endogenous depression	2.72e-05	0.000347	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—TPH2—endogenous depression	2.72e-05	0.000347	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—CACNB2—endogenous depression	2.72e-05	0.000347	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—DPYD—endogenous depression	2.68e-05	0.000341	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—POMC—endogenous depression	2.64e-05	0.000336	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—CACNB2—endogenous depression	2.56e-05	0.000327	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—TPH2—endogenous depression	2.56e-05	0.000327	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—CACNA1C—endogenous depression	2.55e-05	0.000325	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—TPH2—endogenous depression	2.54e-05	0.000324	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—CACNB2—endogenous depression	2.54e-05	0.000324	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—DPYD—endogenous depression	2.52e-05	0.000321	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—DPYD—endogenous depression	2.5e-05	0.000319	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—CACNA1C—endogenous depression	2.49e-05	0.000317	CbGpPWpGaD
Gefitinib—ALB—Metabolism—CYP2D6—endogenous depression	2.48e-05	0.000316	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—endogenous depression	2.45e-05	0.000312	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—CACNA1C—endogenous depression	2.34e-05	0.000299	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—CACNA1C—endogenous depression	2.32e-05	0.000296	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—endogenous depression	2.24e-05	0.000285	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—CYP2D6—endogenous depression	2.23e-05	0.000284	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—TPH1—endogenous depression	2.21e-05	0.000282	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—HTR2A—endogenous depression	2.21e-05	0.000282	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—COMT—endogenous depression	2.18e-05	0.000278	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—CYP2D6—endogenous depression	2.18e-05	0.000277	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—MAOA—endogenous depression	2.17e-05	0.000276	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—COMT—endogenous depression	2.06e-05	0.000263	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—MAOA—endogenous depression	2.05e-05	0.000261	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—CYP2D6—endogenous depression	2.03e-05	0.000259	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—POMC—endogenous depression	1.97e-05	0.000251	CbGpPWpGaD
Gefitinib—ALB—Metabolism—COMT—endogenous depression	1.88e-05	0.00024	CbGpPWpGaD
Gefitinib—ALB—Metabolism—MAOA—endogenous depression	1.87e-05	0.000238	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—POMC—endogenous depression	1.77e-05	0.000225	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—COMT—endogenous depression	1.69e-05	0.000215	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—MAOA—endogenous depression	1.68e-05	0.000214	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—CACNB2—endogenous depression	1.68e-05	0.000214	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—TPH2—endogenous depression	1.68e-05	0.000214	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—DPYD—endogenous depression	1.65e-05	0.00021	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—COMT—endogenous depression	1.65e-05	0.00021	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—MAOA—endogenous depression	1.64e-05	0.000209	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—COMT—endogenous depression	1.55e-05	0.000198	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—MAOA—endogenous depression	1.54e-05	0.000197	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—COMT—endogenous depression	1.54e-05	0.000196	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—CACNA1C—endogenous depression	1.53e-05	0.000195	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—MAOA—endogenous depression	1.53e-05	0.000195	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—POMC—endogenous depression	1.41e-05	0.00018	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—CYP2D6—endogenous depression	1.34e-05	0.000171	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—POMC—endogenous depression	1.33e-05	0.00017	CbGpPWpGaD
Gefitinib—ALB—Metabolism—POMC—endogenous depression	1.22e-05	0.000155	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—POMC—endogenous depression	1.09e-05	0.000139	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—POMC—endogenous depression	1.07e-05	0.000136	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—COMT—endogenous depression	1.02e-05	0.000129	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—MAOA—endogenous depression	1.01e-05	0.000129	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—POMC—endogenous depression	1e-05	0.000128	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—POMC—endogenous depression	9.95e-06	0.000127	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—POMC—endogenous depression	6.57e-06	8.37e-05	CbGpPWpGaD
